| Literature DB >> 33717585 |
De-Hao Tu1, Rirong Qu1, Qi Wang1, Xiangning Fu1.
Abstract
BACKGROUND: The increase in the incidence of esophageal cancers (ECs) combined with fewer surgeons working at large centers will increase the likelihood of surgery for ECs being performed during later hours. This study aimed to compare esophagectomies' operative outcomes for EC performed at different surgical starting times.Entities:
Keywords: Esophageal neoplasms; esophagectomy; prognosis; propensity score-matched; surgical starting time
Year: 2021 PMID: 33717585 PMCID: PMC7947526 DOI: 10.21037/jtd-20-3141
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895
Figure 1Flowchart of participant selection.
Characteristics before and after propensity score matching
| Variables | Overall | Before matching | After matching | |||||
|---|---|---|---|---|---|---|---|---|
| During-hours† (n=669) | After-hours† (n=33) | P value | During-hours† (n=84) | After-hours† (n=33) | P value | |||
| Age, years | 60 [54–65] | 60 [54–65] | 63 [54–67] | 0.179 | 63 [57.5–68] | 63 [54–67] | 0.609 | |
| Sex | 0.149 | 0.812 | ||||||
| Male | 583 (83.0) | 559 (83.56) | 24 (72.73) | 64 (76.19) | 24 (72.73) | |||
| Female | 119 (17.0) | 110 (16.44) | 9 (27.27) | 20 (23.81) | 9 (27.27) | |||
| BMI (kg/m2) | 21.72 (19.95–23.80) | 21.72 (19.95–23.80) | 21.83 (20.12–23.74) | 0.885 | 21.87 (20.14–23.83) | 21.83 (20.15–23.74) | 0.905 | |
| Nutritional status‡ | 0.562 | 0.669 | ||||||
| Normal | 387 (55.1) | 370 (55.31) | 17(51.52) | 43 (51.19) | 17 (51.52) | |||
| Underweight | 72 (10.3) | 67 (10.01) | 5 (15.15) | 8 (8.33) | 5 (15.15) | |||
| Overweight | 243(34.6) | 232 (34.68) | 11 (33.33) | 33 (39.29) | 11 (33.33) | |||
| Smoker index | 0.096 | 0.467 | ||||||
| 0 | 213 (30.3) | 198 (29.6) | 15 (45.45) | 29 (34.52) | 15 (45.45) | |||
| 0–1,000 | 376 (53.6) | 364 (54.41) | 12 (36.36) | 40 (47.62) | 12 (36.36) | |||
| >1,000 | 113 (16.1) | 107 (15.99) | 6 (18.18) | 15 (17.86) | 6 (18.18) | |||
| Alcohol addicted | 413 (58.8) | 396 (59.19) | 17 (51.52) | 0.469 | 42 (50.00) | 17 (51.52) | 1.000 | |
| Charlson comorbidity index | 0.408 | 0.613 | ||||||
| 0 | 452 (64.4) | 427 (63.83) | 25 (75.76) | 57 (67.86) | 25 (75.76) | |||
| 1 | 194 (27.6) | 187 (27.95) | 7 (21.21) | 20 (23.81) | 7 (21.21) | |||
| >1 | 56 (8.0) | 55 (8.22) | 1 (3.03) | 7 (8.33) | 1 (3.03) | |||
| ASA score | 0.196 | 0.497 | ||||||
| I | 63 (9.0) | 60 (8.97) | 3 (9.09) | 7 (8.33) | 3 (9.09) | |||
| II | 525 (74.8) | 504 (75.34) | 21 (63.64) | 62 (73.81) | 21 (63.64) | |||
| III | 114 (16.2) | 105 (15.70) | 9 (27.27) | 15 (17.86) | 9 (27.27) | |||
| Tumor histology | 0.062 | 0.135 | ||||||
| Adenocarcinoma | 20 (2.8) | 652 (97.46) | 30 (90.01) | 82 (97.62) | 30 (90.91) | |||
| Squamous cell carcinoma | 682 (97.1) | 17 (2.54) | 3 (9.09) | 2 (2.38) | 3 (9.09) | |||
| Tumor location | 0.190 | 1.000 | ||||||
| Upper | 57 (8.1) | 55 (8.22) | 2 (6.06) | 4 (4.76) | 2 (6.06) | |||
| Middle | 467 (66.5) | 449 (67.12) | 18 (54.55) | 47 (55.95) | 18 (54.55) | |||
| Lower | 178 (25.4) | 165 (24.66) | 13 (39.39) | 33 (39.29) | 13 (39.39) | |||
| Pathological stage | 0.320 | 0.723 | ||||||
| 0-I | 133 (18.9) | 128 (19.13) | 5 (15.15) | 18 (21.43) | 5 (15.15) | |||
| II | 248 (35.3) | 231 (34.53) | 17 (51.52) | 33 (39.29) | 17 (51.52) | |||
| III | 261 (37.2) | 252 (37.67) | 9 (27.27) | 26 (30.95) | 9 (27.27) | |||
| IV | 60 (8.5) | 58 (8.67) | 2 (6.06) | 7 (8.33) | 2 (6.06) | |||
| Surgeon with high professional title | 350 (49.9) | 329 (49.18) | 21 (63.64) | 0.112 | 44 (52.38) | 21 (63.64) | 0.306 | |
| Approach | <0.001 | 1.000 | ||||||
| McKeown | 215 (30.6) | 333 (49.78) | 6 (18.18) | 16 (19.05) | 6 (18.18) | |||
| Ivor-Lewis | 148 (21.1) | 145 (21.67) | 3 (9.09) | 7 (8.33) | 3 (9.09) | |||
| Sweet | 339 (48.3) | 191 (28.55) | 24 (72.73) | 61 (72.62) | 24 (72.73) | |||
| MIE | 384 (54.7) | 377 (56.35) | 7 (21.21) | <0.001 | 23 (27.38) | 7 (21.21) | 0.639 | |
Values are given as median (IQR) or n (%). †, during-hours group: participants who underwent surgery that started before 17:00; after-hours group: participants who underwent surgery that started after 17:00; ‡, nutritional status defined by Asian adult standard, which is underweight, BMI below 18.5; and overweight, BMI over 23.0. MIE, minimally invasive esophagectomy.
Figure 2RA-CUSUM curve for 1- (A), 2- (B), and 3-year (C) all-cause mortality, showing change-points at 15:34 (P=0.098), 13:22 (P=0.806), and 16:42 (P=0.043). RA-CUSUM, risk adjusted cumulative sum; E, expected; O, observed.
Cox proportional hazards model of participants who underwent esophagectomy
| Start time | Number (%) | Crude HR (95% CI) | Crude P value | Adjusted HR† (95% CI) | Adjusted P† value |
|---|---|---|---|---|---|
| Overall survival | |||||
| 9:00–10:59 | 217 (30.9) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
| 11:00–12:59 | 95 (13.5) | 0.84 (0.58–1.21) | 0.339 | 1.06 (0.69–1.63) | 0.801 |
| 13:00–14:59 | 232 (33.0) | 0.71 (0.53–0.95) | 0.022 | 0.96 (0.66–1.41) | 0.854 |
| 15:00–16:59 | 125 (17.8) | 0.82 (0.58–1.16) | 0.263 | 1.18 (0.77–1.81) | 0.456 |
| 17:00–18:59 | 18 (2.6) | 1.39 (0.75–2.60) | 0.297 | 2.47 (1.25–4.90) | 0.010 |
| 19:00– | 15 (2.1) | 1.18 (0.55–2.53) | 0.679 | 1.49 (0.65–3.43) | 0.348 |
| Disease-free survival | |||||
| 9:00–10:59 | 217 (30.9) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
| 11:00–12:59 | 95 (13.5) | 0.78 (0.55–1.11) | 0.175 | 0.95 (0.63–1.44) | 0.813 |
| 13:00–14:59 | 232 (33.0) | 0.71 (0.54–0.94) | 0.015 | 1.00 (0.69–1.44) | 0.991 |
| 15:00–16:59 | 125 (17.8) | 0.84 (0.61–1.15) | 0.272 | 1.16 (0.77–1.74) | 0.478 |
| 17:00–18:59 | 18 (2.6) | 1.28 (0.69–2.39) | 0.428 | 2.14 (1.08–4.21) | 0.028 |
| 19:00– | 15 (2.1) | 1.24 (0.60–2.53) | 0.559 | 1.89 (0. 87–4.14) | 0.110 |
†, adjustment was performed for age, gender, nutritional status, smoking index, alcohol consumption, Charlson comorbidity index, ASA, tumor pathology, pathologic stage, tumor location, approach, MIE, and surgeon with high professional title. HR, hazard ratio; CI, confidence interval.
Peri-operative outcomes
| Variables | Overall | After matching | |||||
|---|---|---|---|---|---|---|---|
| During-hours† (n=669) | After-hours† (n=33) | P value | During-hours† (n=84) | After-hours† (n=33) | P value | ||
| Operative time, min | 379 [300–440] | 239 [205–320] | <0.001 | 309 [234.5–372] | 239 [205–320] | 0.014 | |
| Bleeding volume, mL | 200 [139–400] | 200 [135–300] | 0.636 | 148 [100–300] | 200 [135–300] | 0.080 | |
| Intraoperative transfusion | 103 (15.40) | 3 (9.09) | 0.456 | 12 (14.29) | 3 (9.09) | 0.552 | |
| Duration of post-operative hospitalization, day | 16 [14–18] | 15 [14–19] | 0.774 | 16 [14–17.5] | 15 [14–19] | 0.688 | |
| Complications | |||||||
| Anastomosis leak | 59 (8.82) | 4 (12.12) | 0.527 | 6 (7.14) | 4 (12.12) | 0.465 | |
| Respiratory complications | 178 (26.61) | 15 (45.45) | 0.026 | 19 (22.62) | 15 (45.45) | 0.023 | |
| Cardiac complications | 13 (1.94) | 3 (9.09) | 0.035 | 5 (5.95) | 3 (9.09) | 0.685 | |
| Chylothorax | 17 (2.54) | 2 (6.06) | 0.223 | 2 (2.38) | 2 (6.06) | 0.316 | |
| Hoarseness | 119 (17.79) | 6 (18.18) | 1.000 | 11 (13.10) | 6 (18.18) | 0.562 | |
| 90-day all-cause mortality | 23 (3.44) | 3 (9.09) | 0.118 | 0 (0) | 3 (9.09) | 0.021 | |
Values are given as median [IQR] or n (%). †, during-hours group: participants who underwent surgery that started before 17:00, after-hours group: participants who underwent surgery that started after 17:00.
Post-operative pathological outcomes
| Variables | Before matching | After matching | |||||
|---|---|---|---|---|---|---|---|
| During-hours† (n=669) | After-hours† (n=33) | P value | During-hours† (n=84) | After-hours† (n=33) | P value | ||
| Depth of tumor | 0.735 | 0.303 | |||||
| Tis-T1 | 111 (16.59) | 3 (9.09) | 15 (17.86) | 3 (9.09) | |||
| T2 | 163 (24.36) | 9 (27.27) | 24 (28.57) | 9 (27.27) | |||
| T3 | 338 (50.52) | 18 (54.55) | 43 (51.19) | 18 (54.55) | |||
| T4 | 57 (8.52) | 3 (9.09) | 2 (2.38) | 3 (9.09) | |||
| N classification | 0.564 | 0.836 | |||||
| N0 | 375 (56.05) | 23 (69.70) | 52 (61.90) | 23 (69.70) | |||
| N1 | 173 (25.86) | 6 (18.18) | 15 (17.86) | 6 (18.18) | |||
| N2 | 74 (11.06) | 2 (6.06) | 10 (11.90) | 2 (6.06) | |||
| N3 | 47 (7.03) | 2 (6.06) | 7 (8.33) | 2 (6.06) | |||
| Degree of differentiation | 0.294 | 0.725 | |||||
| G1 | 109 (16.95) | 7 (21.21) | 17 (21.25) | 7 (21.21) | |||
| G2 | 337 (52.41) | 20 (60.61) | 43 (53.75) | 20 (60.61) | |||
| G3 | 197 (30.64) | 6 (18.18) | 20 (25.00) | 6 (18.18) | |||
| Positive resection margin | 22 (3.29) | 1 (3.03) | 1.000 | 0 (0.00) | 1 (3.03) | 0.282 | |
| Number of the metastatic lymph node | 0 [0–2] | 0 [0–1] | 0.284 | 0 [0–2] | 0 [0–1] | 0.486 | |
| Number of the harvested lymph node | 16 [11–23] | 20 [14–26] | 0.198 | 18 [11.5–23] | 20 [14–26] | 0.444 | |
| Number of stations of the metastatic lymph node‡ | 0 [0–1] | 0 [0–1] | 0.314 | 0 [0–1] | 0 [0–1] | 0.621 | |
| Number of stations of the harvested lymph node‡ | 4 [3–5] | 4 [3–5] | 0.907 | 4 [2–5] | 4 [3–5] | 0.380 | |
Values are given as median [IQR] or n (%). †, during-hours group patients who underwent surgery that started before 17:00, after-hours group patients who underwent surgery that started after 17:00; ‡, lymph node stations were named according to Japanese classification (21).
Figure 3Kaplan-Meier curves for 5-year OS with 95% CIs among all patients (A), and after propensity score matching (B), and that for 5-year DFS with 95% CI among all patients (C), and after propensity score matching (D). Differences between the groups were assessed by the log-rank test. During-hours group: participants who underwent surgery that started before 17:00; after-hours group: patients who underwent surgery that started after 17:00. OS, overall survival; CI, confidence interval; DFS, disease-free survival.